A detailed history of Advantage Alpha Capital Partners LP transactions in Stevanato Group S.P.A. stock. As of the latest transaction made, Advantage Alpha Capital Partners LP holds 230,824 shares of STVN stock, worth $4.85 Million. This represents 1.1% of its overall portfolio holdings.

Number of Shares
230,824
Previous 446,967 48.36%
Holding current value
$4.85 Million
Previous $8.2 Million 43.69%
% of portfolio
1.1%
Previous 1.86%

Shares

10 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 13, 2024

SELL
$17.98 - $22.02 $3.89 Million - $4.76 Million
-216,143 Reduced 48.36%
230,824 $4.62 Million
Q2 2024

Aug 13, 2024

BUY
$16.93 - $31.33 $7.57 Million - $14 Million
446,967 New
446,967 $8.2 Million
Q3 2023

Nov 14, 2023

SELL
$26.91 - $35.49 $2.06 Million - $2.72 Million
-76,678 Reduced 45.64%
91,318 $2.71 Million
Q2 2023

Aug 14, 2023

SELL
$25.15 - $32.86 $3.59 Million - $4.69 Million
-142,837 Reduced 45.95%
167,996 $5.44 Million
Q1 2023

May 12, 2023

SELL
$17.5 - $25.9 $5.73 Million - $8.48 Million
-327,603 Reduced 51.31%
310,833 $8.05 Million
Q4 2022

Feb 14, 2023

SELL
$13.95 - $19.28 $2.9 Million - $4 Million
-207,603 Reduced 24.54%
638,436 $11.5 Million
Q3 2022

Nov 14, 2022

BUY
$14.66 - $18.3 $1.34 Million - $1.67 Million
91,362 Added 12.11%
846,039 $14.3 Million
Q2 2022

Aug 12, 2022

BUY
$14.1 - $20.26 $6.55 Million - $9.41 Million
464,382 Added 159.97%
754,677 $11.9 Million
Q1 2022

May 16, 2022

BUY
$15.23 - $21.47 $2.06 Million - $2.9 Million
134,951 Added 86.87%
290,295 $5.84 Million
Q4 2021

Feb 14, 2022

BUY
$21.65 - $27.0 $3.36 Million - $4.19 Million
155,344 New
155,344 $3.49 Million

Others Institutions Holding STVN

About Stevanato Group S.p.A.


  • Ticker STVN
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Instruments & Supplies
  • Shares Outstandng 264,700,000
  • Market Cap $5.56B
  • Description
  • Stevanato Group S.p.A. engages in the design, production, and distribution of products and processes to provide integrated solutions for pharma and healthcare. Its principal products include containment solutions, drug delivery systems, medical devices, diagnostic, analytical services, visual inspection machines, assembling and packaging machine...
More about STVN
Track This Portfolio

Track Advantage Alpha Capital Partners LP Portfolio

Follow Advantage Alpha Capital Partners LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Advantage Alpha Capital Partners LP, based on Form 13F filings with the SEC.

News

Stay updated on Advantage Alpha Capital Partners LP with notifications on news.